Posted in | News | MEMS - NEMS | Nanoelectronics

MEMSCAP Completes Die Level Testing on MEMS-Based Variable Optical Attenuators

MEMSCAP (NYSE Euronext: MEMS) (Paris:MEMS), the leading provider of innovative solutions based on MEMS (micro-electro-mechanical systems) technology, including optical components, today announces it has successfully completed die level reliability testing beyond 200 millions cycles on its Thermally Actuated Variable Optical Attenuators.

Fueled by the demand for faster internet connection and multiservice solutions, investments in existing and new optical network infrastructures are steadily growing to benefit the optical networking industry. Optical system integrators are looking for proven high quality and high reliability components to be safely integrated in complex optical modules operating up to 100 GBits. MEMS based Variable Optical Attenuators are gaining momentum and market share over competing traditional technologies in optical networks applications ranging from optical modules protection to the growing segment of Power Management.

MEMSCAP has supplied multiple customers from the beginning of its innovative photonic road map up to full product release, building a track record for catering to the needs of the optical community and providing state-of-the-art products in production.

“MEMSCAP is the N°1 Supplier of Optical MEMS Chips for Variable Optical Attenuators in optical telecom markets, a segment growing at an impressive CAGR of 28% from 2009 to 2014, as MEMS-based VOAs increasingly displace non-MEMS solutions”, said Jérémie Bouchaud, Director and Principal Analyst for MEMS and Sensors at IHS iSuppli (see iSuppli H2 2010 High Value MEMS Market Tracker).

MEMSCAP’s commitment to high quality over the years has resulted in numerous breakthrough products exhibiting superior performance and reliability. Recent die level tests on the Thermally Actuated MEMS Variable Optical Attenuator product line confirmed that the MEMS devices operate within all specifications even after 200 millions cycles with all optical, mechanical and electrical properties remaining within their strict initial specifications. The key operating parameters of electrical resistance and power consumption of the units exhibit excellent stability over the full duration of the test.

Capitalizing on its optical MEMS Intellectual Property in design and manufacturing, MEMSCAP has developed a wide variety of Thermally Actuated Variable Optical Attenuators in both Normally Open and Normally Closed configurations, including different die sizes, with or without metalized backside.

MEMSCAP’s Variable Optical Attenuator dies have been designed to fit most packaging technologies available on the market and in closed loop mode exhibit superior optical power attenuation stability.

Source: http://www.memscap.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    MEMSCAP. (2019, February 12). MEMSCAP Completes Die Level Testing on MEMS-Based Variable Optical Attenuators. AZoNano. Retrieved on November 21, 2024 from https://www.azonano.com/news.aspx?newsID=21705.

  • MLA

    MEMSCAP. "MEMSCAP Completes Die Level Testing on MEMS-Based Variable Optical Attenuators". AZoNano. 21 November 2024. <https://www.azonano.com/news.aspx?newsID=21705>.

  • Chicago

    MEMSCAP. "MEMSCAP Completes Die Level Testing on MEMS-Based Variable Optical Attenuators". AZoNano. https://www.azonano.com/news.aspx?newsID=21705. (accessed November 21, 2024).

  • Harvard

    MEMSCAP. 2019. MEMSCAP Completes Die Level Testing on MEMS-Based Variable Optical Attenuators. AZoNano, viewed 21 November 2024, https://www.azonano.com/news.aspx?newsID=21705.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.